SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
May 8, 2008 (Date of Report)
(Date of Earliest Event Reported)
Trubion Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in Charter)
         
Delaware   001-33054   52-2385898
(State or Other Jurisdiction   (Commission File No.)   (IRS Employer
of Incorporation)       Identification No.)
2401 Fourth Avenue, Suite 1050, Seattle, WA 98121
(Address of Principal Executive Offices, including Zip Code)
(206) 838-0500
(Registrant’s Telephone Number, Including Area Code)
None
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

 

Item 2.02. Results of Operations and Financial Condition.
On May 8, 2008, Trubion Pharmaceuticals, Inc. (“Trubion”) announced its financial results for the first quarter ended March 31, 2008. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In addition, on May 8, 2008, Trubion held a conference call to discuss its financial results for the first quarter ended March 31, 2008. A transcript of the call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits .
(d)   Exhibits.
  99.1   Press Release of Trubion Pharmaceuticals, Inc., dated May 8, 2008.
  99.2   First Quarter 2008 Earnings Call Transcript of Trubion Pharmaceuticals, Inc. dated May 8, 2008.

 

 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  TRUBION PHARMACEUTICALS, INC.
  		 
Date: May 9, 2008  By:   /s/ Michelle Burris    
    Michelle Burris   
    Senior Vice President and Chief Financial Officer   

 

 

         
INDEX TO EXHIBITS
     
Exhibit No.   Description
99.1
  Press Release of Trubion Pharmaceuticals, Inc., dated May 8, 2008.
99.2
  First Quarter 2008 Earnings Call Transcript of Trubion Pharmaceuticals, Inc. dated May 8, 2008.

 

Trubion Pharmaceuticals (MM) (NASDAQ:TRBN)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Trubion Pharmaceuticals (MM) Charts.
Trubion Pharmaceuticals (MM) (NASDAQ:TRBN)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Trubion Pharmaceuticals (MM) Charts.